Synergy Innovation Co (XKRX:048870) ROCE % : 8.75% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Synergy Innovation Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Synergy Innovation Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 8.75%.

Synergy Innovation Co ROCE % Historical Data

The historical data trend for Synergy Innovation Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Innovation Co ROCE % Chart

Synergy Innovation Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

10.41

-14.90

11.21

10.94

14.37

Synergy Innovation Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															15.54	0.61	6.86	3.30	8.75

Synergy Innovation Co ROCE % Calculation

Synergy Innovation Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	28733.875	/	( ( (227375.842 - 52224.094)	+	(285901.064 - 61184.028) )	/ 2 )
	=	28733.875	/	( (175151.748	+	224717.036)	/ 2 )
	=	28733.875	/	199934.392
	=	14.37 %

Synergy Innovation Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	19555.072	/	( ( (248329.6 - 26195.932)	+	(285901.064 - 61184.028) )	/ 2 )
	=	19555.072	/	( ( 222133.668	+	224717.036 )	/ 2 )
	=	19555.072	/	223425.352
	=	8.75 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Synergy Innovation Co (XKRX:048870) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Synergy Innovation Co ROCE % Related Terms

Thank you for viewing the detailed overview of Synergy Innovation Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Innovation Co (XKRX:048870) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synergy Innovation Co Ltd (XKRX:048870) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

124 Myeong-dong Dong 601, Seongnam-si, Gyeonggi-do, Seoul, KOR

Website

http://www.synergyinno.com

Synergy Innovation Co Ltd is a South Korean company engaged in research and development in various fields like genetics, new drugs, and medical devices and materials. The business of the company includes bio business and new drug development.

Synergy Innovation Co (XKRX:048870) Headlines

No Headlines